Have a personal or library account? Click to login
Post COVID-19 vaccination and adverse events: correspondence Cover

Post COVID-19 vaccination and adverse events: correspondence

Paid access
|Dec 2022

References

  1. Nnawuba KC, Boral BM, Donnell RW. Probable warm autoimmune hemolytic anemia proceeding the administration of the Pfizer mRNA COVID-19 vaccine. Immunohematology 2022;38:106–7. doi:10.21307/immunohematology-2022-051.
  2. Joob B, Wiwanitkit V. Letter to the editor: coronavirus disease 2019 (COVID-19), infectivity, and the incubation period. J Prev Med Public Health 2020;53:70.
  3. Thiessen K, Kraleti S. Cephalexin-induced haemolytic anaemia: a case report. J Clin Pharm Ther 2017;42:615–7. doi:10.1111/ jcpt.12542.
  4. Kebayoon A, Wiwanitkit V. Dengue after COVID-19 vaccination: possible and might be missed. Clin Appl Thromb Hemost 2021;27:10760296211047229.
  5. Čiučiulkaitė I, Möhlendick B, Thümmler, et al. GNB3 c.825c>T polymorphism influences T-cell but not antibody response following vaccination with the mRNA-1273 vaccine. Front Genet 2022;13:932043.
  6. D’Abronzo LS, Barros MMO, Bordin JO, Figueiredo MS. Analysis of polymorphisms of TNF-α, LT-α, IL-10, IL-12 and CTLA-4 in patients with warm autoimmune haemolytic anaemia. Int J Lab Hematol 2012;34:356–61.
DOI: https://doi.org/10.21307/immunohematology-2022-059 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 141 - 141
Published on: Dec 28, 2022
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2022 Rujittika Mungmunpuntipantip, Viroj Wiwanitkit, published by American National Red Cross
This work is licensed under the Creative Commons License.